Search by Drug Name or NDC

    NDC 61476-0104-05 Alyglo 100 mg/mL Details

    Alyglo 100 mg/mL

    Alyglo is a INTRAVENOUS LIQUID in the PLASMA DERIVATIVE category. It is labeled and distributed by GC Biopharma Corp.. The primary component is HUMAN IMMUNOGLOBULIN G.

    Product Information

    NDC 61476-0104
    Product ID 61476-104_692b3911-b195-4499-9790-37e0812b3cde
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Alyglo
    Proprietary Name Suffix n/a
    Non-Proprietary Name Human immunoglobulin G
    Product Type PLASMA DERIVATIVE
    Dosage Form LIQUID
    Route INTRAVENOUS
    Active Ingredient Strength 100
    Active Ingredient Units mg/mL
    Substance Name HUMAN IMMUNOGLOBULIN G
    Labeler Name GC Biopharma Corp.
    Pharmaceutical Class Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA125743
    Listing Certified Through 2024-12-31

    Package

    NDC 61476-0104-05 (61476010405)

    NDC Package Code 61476-104-05
    Billing NDC 61476010405
    Package 1 VIAL, GLASS in 1 CARTON (61476-104-05) / 50 mL in 1 VIAL, GLASS (61476-104-01)
    Marketing Start Date 2023-12-15
    NDC Exclude Flag N
    Pricing Information N/A